Please enable Javascript to use all features and improve your user experience.
DGTI 2022
Programme
People
Search
EN
All people
Prof. Dr. Reinhard Henschler
Sort by Type
Date
Chair
22/09/2022
16:30
–
18:15
Postersession
Hämovigilanz | Immunhämatologie und immunologische Grundlagen II. | Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie |Pädiatrische Transfusionsmedizin
Foyer 1.2
23/09/2022
08:30
–
10:00
Vortragssitzung
Neue Arzneimittel aus Blut
Arnold Schönberg
Redner
21/09/2022
15:00
–
15:20
15 Min.
5 Min.
Vortrag
VS-6-2
Transfusion of thrombocytes according to guidelines and with extended antigen matching
Speaker
21/09/2022
15:20
–
15:30
6 Min.
4 Min.
Abstractvortrag
VS-6-3
Analysis of Platelet Product Utilization at a University Hospital Reveals Optimization Potential in Guideline Adherence
16. Rechtliche Grundlagen, Qualitätssicherung und regulatorische Aspekte, 9. Hämotherapie
22/09/2022
16:30
–
16:35
3 Min.
2 Min.
Poster
PS-3-1
Systematic analysis of adverse transfusion reactions reveals both, transfusion adverse events and handling errors
6. Hämovigilanz, 9. Hämotherapie
22/09/2022
17:00
–
17:05
3 Min.
2 Min.
Poster
PS-1-9
Neonatal red blood concentrates contain highly predictable extracellular K
+
levels, which can be controlled by washing and may allow extended shelf life
3. Blutkomponenten – Herstellung und Qualitätskontrolle, 9. Hämotherapie
Further involvements
21/09/2022
15:00
–
15:10
6 Min.
4 Min.
Abstractvortrag
VS-8-2
The effectiveness of telephone surveys on the retention of first-time donors – A randomized controlled trial
1. Blutspende und Donormanagement, 2. Versorgungsforschung
21/09/2022
15:20
–
15:30
6 Min.
4 Min.
Abstractvortrag
VS-6-3
Analysis of Platelet Product Utilization at a University Hospital Reveals Optimization Potential in Guideline Adherence
16. Rechtliche Grundlagen, Qualitätssicherung und regulatorische Aspekte, 9. Hämotherapie
22/09/2022
09:50
–
10:00
6 Min.
4 Min.
Abstractvortrag (Best Abstract)
VS-10-5 (Best Abstract)
Screening for Illicit Drugs in Blood Donors Reveals Low but Steady Incidence of THC and Amphetamines in an Urban-predominated Blood Donor Repertoire
1. Blutspende und Donormanagement, 5. Infektionssicherheit von Blutprodukten
22/09/2022
16:30
–
16:35
3 Min.
2 Min.
Poster
PS-3-1
Systematic analysis of adverse transfusion reactions reveals both, transfusion adverse events and handling errors
6. Hämovigilanz, 9. Hämotherapie
22/09/2022
17:00
–
17:05
3 Min.
2 Min.
Poster
PS-1-9
Neonatal red blood concentrates contain highly predictable extracellular K
+
levels, which can be controlled by washing and may allow extended shelf life
3. Blutkomponenten – Herstellung und Qualitätskontrolle, 9. Hämotherapie
22/09/2022
17:05
–
17:10
3 Min.
2 Min.
Poster
PS-1-10
Increase of whole blood donation volume from 450 to 500 ml results in qualitative and quantitative improvements in all three derived products
3. Blutkomponenten – Herstellung und Qualitätskontrolle, 9. Hämotherapie
22/09/2022
17:20
–
17:25
3 Min.
2 Min.
Poster
PS-4-13
Transfer of Human Therapeutic T cells into Expansion Cultures Used for Generation of CAR T Cells is Associated with Discordant Regulation of Adhesion Receptor and Cytoskeletal Genes
12. Zelltherapie und Gentherapie
22/09/2022
17:20
–
17:25
3 Min.
2 Min.
Poster
PS-1-12
Exchange transfusion for hyperleukocytosis in childhood leukemia – A case report
4. Präparative und Therapeutische Apherese, 9. Hämotherapie
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy